TY - JOUR T1 - High-dose barium impaction therapy is a practical option for reducing recurrence of colonic diverticular bleeding JF - Evidence Based Medicine JO - Evid Based Med SP - 131 LP - 131 DO - 10.1136/ebmed-2015-110192 VL - 20 IS - 4 AU - Mikihiro Fujiya Y1 - 2015/08/01 UR - http://ebm.bmj.com/content/20/4/131.abstract N2 - Commentary on: Nagata N, Niikura R, Shimbo T, et al. High-dose barium impaction therapy for the recurrence of colonic diverticular bleeding: a randomised controlled trial. Ann Surg 2015;261: 269–75.OpenUrlCrossRefPubMedColonic diverticular bleeding (CDB) accounts for approximately 40% of all cases of acute lower gastrointestinal bleeding. Most cases of CDB resolve without surgery, although the rebleeding rate is high even when therapeutic procedures, including endoscopy and angiography, are successful. This leads to frequent examinations, hospitalisation and blood transfusion and a decrease in the quality of life. It has been reported that transanal administration of a high-dose barium enema provides better clinical outcomes for initial haemostasis and the long-term prevention of rebleeding than conservative therapy. However, no controlled study concerning this procedure has been conducted. The present randomised controlled trial investigated the efficacy of barium impaction … ER -